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T R A U M AT I C  B R A I N  I N J U RY
Evidence, Guidelines and Treatment Variation
1. The level of evidence for management of severe TBI remains limited, with few robust studies 
and even fewer studies actually showing benefit of the interventions studied. (this thesis)
2. The available evidence on the medical management of severe TBI should be summarized and 
“translated” into guideline recommendations in the most comprehensive way possible, while 
avoiding the “cookbook”/”one-fits-all” approach. (this thesis)
3. Marked practice variation exists in management of severe TBI, even on topics where 
consensus is expected based on high-level evidence from RCTs or the recommendations in 
the Brain Trauma Foundation guidelines. (this thesis)
4. Although the only available RCT comparing ventricular devices to intraparenchymal 
monitors showed lower mortality and better functional outcome with ventricular devices, 
in a meta-analysis this result is overturned; the use of ventricular devices instead of 
intraparenchymal monitors in the treatment of severe TBI does not offer benefit in terms of 
mortality or functional outcome. (this thesis)
5. When using a comparative effectiveness approach, the use of ventricular devices instead of 
intraparenchymal monitors to guide treatment of severe TBI leads to less decompressive 
craniectomies. (this thesis)
6. The validity of observational studies and their proper interpretation can be improved by 
using falsification end points, validation datasets, and prespecified rules when the study 
hypotheses should be considered confirmed or rejected. (Ioannidis et al 2016 CMAJ)
7. For some outcomes it may be difficult to obtain definitive evidence from large trials, and 
observational data could then offer the best possible guidance, but caution is needed to 
prevent misguided clinical decision making. (Ioannidis et al 2016 CMAJ)
8. Subgroup findings should be exploratory, and only exceptionally should they affect the trial’s 
conclusions. (Kent, Steyerberg et al 2018, BMJ)
9. Science is understood, up to a certain extent, to be an accumulative, iterative, self-correcting 
endeavor, where mistakes are a normal short-term side-effect of a long-term process of 
accumulating evidence. (Card et al 2014, Stat Journal Club)
10. Advocates of evidence-based medicine have criticized the adoption of interventions evaluated 
by using only observational data. […] everyone might benefit if the most radical protagonists 
of evidence-based medicine organized and participated in a double blind, randomized, 
placebo controlled, crossover trial of the parachute for prevention of mortality and severe 
morbidity. (Smith et al, BMJ 2003)
11. “Even meaning and destiny themselves can be read in ordinary things, if you have the gift”. 
(Stephen Fry, Mythos. The Greek Myths Retold)
